XML 51 R40.htm IDEA: XBRL DOCUMENT
v3.21.2

Commitments and Contingencies - License Agreement (Details) - USD ($) | 1 Months Ended | 6 Months Ended |
--- | --- | --- | ---
Aug. 31, 2021 | Nov. 30, 2020 | Oct. 31, 2020 | Nov. 30, 2018 | Jun. 30, 2021 | Dec. 31, 2020
Commitments and Contingencies |  |  |  |  |  |
One-time non-refundable fee of license agreement |  |  |  | $ 50,000 |  |
Reimbursement of Licensor's patent costs at execution of the License |  |  |  | 145,000 |  |
Minimum annual license fee |  |  |  | $ 25,000 |  |
Period within each anniversary of the effective date of the License that minimum annual license fee must be paid |  |  |  | 60 days |  |
Accrued license payments |  |  |  |  | $ 59,957 | $ 42,300
Maximum total milestone payments |  |  |  |  | $ 1,550,000 |
Period within which the milestone payments should be paid upon achievement of the milestone |  |  |  |  | 60 days |
Milestone payment due when enrollment of first patient in a phase II clinical trial of a therapeutic product or process |  |  |  |  | $ 100,000 |
Milestone payment due when enrollment of first patient in a phase III clinical trial of a therapeutic product or process |  |  |  |  | 200,000 |
Milestone payment due when first commercial sale of a therapeutic product or process |  |  |  |  | 1,000,000 |
Milestone payment due when filing of an application for regulatory approval of a clinical diagnostic product or process |  |  |  |  | 100,000 |
Milestone payment due when first regulatory approval of a clinical diagnostic product or process |  |  |  |  | $ 150,000 |
Royalties calculated as a percentage to on net sales of licensed products for therapeutic products or processes |  |  |  |  | 3.00% |
Royalties calculated as a percentage to on net sales of licensed products for clinical diagnostic products and processes |  |  |  |  | 6.00% |
Royalties calculated as a percentage of any and all sublicense income |  |  |  |  | 30.00% |
Notice period for terminating License |  |  |  |  | 90 days |
Period after the first commercial sale that the License shall continue if not terminated by the company |  |  |  |  | 10 years |
Royalty percentage beyond the term of the License |  |  |  |  | 1.50% |
Minimum annual license fee for Patent Family 1 |  | $ 30,000 | $ 25,000 |  |  |
Minimum annual license fee related to Patent Family 2 |  |  |  |  | $ 10,000 |
Terms of option agreement with Licensor | 6 months |  |  |  |  |
Cost of option agreement | $ 5,000 |  |  |  |  |
Terms of extended option agreement with Licensor | 6 months |  |  |  |  |
Cost of extended option agreement | $ 5,000 |  |  |  |  |

X
- Definition Carrying value as of the balance sheet date of obligations incurred through that date and payable for license payments. + References No definition available. + Details
Name: | rnaz_AccruedLicensePayments
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Cost of extended option agreement. + References No definition available. + Details
Name: | rnaz_CostOfExtendedOptionAgreement
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Cost of option agreement. + References No definition available. + Details
Name: | rnaz_CostOfOptionAgreement
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Maximum total milestone payments. + References No definition available. + Details
Name: | rnaz_MaximumTotalMilestonePayments
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payment due when enrollment of first patient in a phase II clinical trial of a therapeutic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenEnrollmentOfFirstPatientInPhaseIiClinicalTrialOfTherapeuticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payment due when enrollment of first patient in a phase III clinical trial of a therapeutic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenEnrollmentOfFirstPatientInPhaseIiiClinicalTrialOfTherapeuticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payment due when filing of an application for regulatory approval of a clinical diagnostic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenFilingOfApplicationForRegulatoryApprovalOfClinicalDiagnosticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payment due when first commercial sale of a therapeutic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenFirstCommercialSaleOfTherapeuticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Milestone payment due when first regulatory approval of a clinical diagnostic product or process. + References No definition available. + Details
Name: | rnaz_MilestonePaymentDueWhenFirstRegulatoryApprovalOfClinicalDiagnosticProductOrProcess
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | instant

X
- Definition Minimum annual license fee. + References No definition available. + Details
Name: | rnaz_MinimumAnnualLicenseFee
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum annual license fee for Patent Family 1. + References No definition available. + Details
Name: | rnaz_MinimumAnnualLicenseFeeForPatentFamily1
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Minimum annual license fee related to Patent Family 2. + References No definition available. + Details
Name: | rnaz_MinimumAnnualLicenseFeeRelatedToPatentFamily2
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Notice period for terminating License. + References No definition available. + Details
Name: | rnaz_NoticePeriodForTerminatingLicense
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition One-time non-refundable fee for license of license agreement. + References No definition available. + Details
Name: | rnaz_OneTimeNonRefundableFeeOfLicenseAgreement
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Period after the first commercial sale that the License shall continue if not terminated by the company. + References No definition available. + Details
Name: | rnaz_PeriodAfterFirstCommercialSaleThatLicenseShallContinueIfNotTerminatedByCompany
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period within each anniversary of the effective date of the License that minimum annual license fee must be paid. + References No definition available. + Details
Name: | rnaz_PeriodWithinEachAnniversaryOfEffectiveDateOfLicenseThatMinimumAnnualLicenseFeeMustBePaid
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Period within which the milestone payments should be paid upon achievement of the milestone. + References No definition available. + Details
Name: | rnaz_PeriodWithinWhichMilestonePaymentsShouldBePaidUponAchievementOfMilestone
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Reimbursement of Licensor's patent costs at execution of the License. + References No definition available. + Details
Name: | rnaz_ReimbursementOfLicensorsPatentCostsAtExecutionOfLicense
Namespace Prefix: | rnaz_
Data Type: | xbrli:monetaryItemType
Balance Type: | debit
Period Type: | duration

X
- Definition Royalties calculated as a percentage of any and all sublicense income. + References No definition available. + Details
Name: | rnaz_RoyaltiesCalculatedAsPercentageOfAnyAndAllSublicenseIncome
Namespace Prefix: | rnaz_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties calculated as a percentage to on net sales of licensed products for clinical diagnostic products and processes. + References No definition available. + Details
Name: | rnaz_RoyaltiesCalculatedAsPercentageToOnNetSalesOfLicensedProductsForClinicalDiagnosticProductsAndProcesses
Namespace Prefix: | rnaz_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalties calculated as a percentage to on net sales of licensed products for therapeutic products or processes. + References No definition available. + Details
Name: | rnaz_RoyaltiesCalculatedAsPercentageToOnNetSalesOfLicensedProductsForTherapeuticProductsOrProcesses
Namespace Prefix: | rnaz_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Royalty percentage beyond the term of the License. + References No definition available. + Details
Name: | rnaz_RoyaltyPercentageBeyondTermOfLicense
Namespace Prefix: | rnaz_
Data Type: | num:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Terms of extended option agreement with Licensor. + References No definition available. + Details
Name: | rnaz_TermsOfExtendedOptionAgreementWithLicensor
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Terms of option agreement with Licensor. + References No definition available. + Details
Name: | rnaz_TermsOfOptionAgreementWithLicensor
Namespace Prefix: | rnaz_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_CommitmentsAndContingenciesDisclosureAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration